These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22464160)

  • 1. [Use of freeze-dried plasma in the management of bleeding in a child with hemophilia in Djibouti].
    Maurin O; Boulesteix G; Eve O; Bertani A; Martinaud C; Kaiser E
    Ann Fr Anesth Reanim; 2012 May; 31(5):491-2. PubMed ID: 22464160
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of bleeding in a child with haemophilia in Africa with freeze-dried plasma.
    Maurin O; Martinaud C; Boulesteix G; Eve O; Bertani A; Goudard Y; Kaiser E
    Haemophilia; 2012 Jan; 18(1):e38-9. PubMed ID: 22117648
    [No Abstract]   [Full Text] [Related]  

  • 3. Lyophilized cryoprecipitate for children with hemophilia A.
    Nuchprayoon I; Sahasittiwat S; Kittikalayawong A; Chantanakajornfung A
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S293-7. PubMed ID: 12188426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Freeze dried cryoprecipitate: a clinical evaluation.
    Hambley H; Davidson JF; Walker ID; Small M; Prentice CR
    J Clin Pathol; 1983 May; 36(5):574-6. PubMed ID: 6404949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS and preventive treatment in hemophilia.
    Desforges JF
    N Engl J Med; 1983 Jan; 308(2):94-5. PubMed ID: 6216409
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy and safety of lyophilized cryoprecipitate in hemophilia A.
    Chuansumrit A; Isarangkura P; Chantanakajornfung A; Kuhathong K; Pintadit P; Jitpraphai C; Hathirat P; Nuchprayoon C
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S69-73. PubMed ID: 10730521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Self-sufficiency with factor VIII in Norway. Use of freeze-dried cryoprecipitates instead of purified factor VIII concentrates].
    Solheim BG; Evensen SA; Stavem P; Glomstein A
    Tidsskr Nor Laegeforen; 1986 Jan; 106(1):16-8. PubMed ID: 3082031
    [No Abstract]   [Full Text] [Related]  

  • 8. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group.
    Schwartz RS; Abildgaard CF; Aledort LM; Arkin S; Bloom AL; Brackmann HH; Brettler DB; Fukui H; Hilgartner MW; Inwood MJ
    N Engl J Med; 1990 Dec; 323(26):1800-5. PubMed ID: 2123300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologic considerations in the management of hemophilia.
    Briggs DK
    Pathobiol Annu; 1971; 1():205-14. PubMed ID: 4950380
    [No Abstract]   [Full Text] [Related]  

  • 10. Some complications of the therapy of classic hemophilia.
    Ratnoff OD
    J Lab Clin Med; 1984 May; 103(5):653-9. PubMed ID: 6425440
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bleeding times in haemophilia patients treated with lyophilised antihaemophilic globulin (AHG) (author's transl)].
    Sutor AH; Jesdinsky-Buscher CJ
    Dtsch Med Wochenschr; 1976 Nov; 101(47):1715-9. PubMed ID: 991757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Use and misuse of cryoprecipitate.
    Hensley MJ
    N Engl J Med; 1975 Jun; 292(24):1299. PubMed ID: 1128599
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of management of patients with haemophilia.
    Carter F; Forbes CD; MacFarlane JD; Prentice CR
    Br Med J; 1976 Aug; 2(6033):465-7. PubMed ID: 953611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycine-precipitated antihemophilic factor concentrates and their clinical use.
    Wagner RH; Roberts HR; Webster WP; Shanbrom E; Brinkhous KM
    Thromb Diath Haemorrh Suppl; 1968; 35():41-8. PubMed ID: 5761073
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of the haemophiliac factor.
    Coutts AM
    Cent Afr J Med; 1997 Sep; 43(9):277-8. PubMed ID: 9509651
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylactic replacement therapy in hemophilia. A case report (author's transl)].
    Mitterstieler G
    Padiatr Padol; 1976; 11(2-2):469-74. PubMed ID: 967509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryoprecipitate lyophilized in single donor units for treatment of haemophiliacs.
    Margolis J; Rhoades P
    Med J Aust; 1979 Jun; 1(11):523-4. PubMed ID: 470710
    [No Abstract]   [Full Text] [Related]  

  • 19. Prepooled cryoprecipitate for treatment of hemophilia A.
    Menitove JE; Spero JA; Richards WA; Lewis JH; Montgomery RR; Gill JC; Hasiba U; Wheeler DV; Sherwin JA; Russell-Vaskov S; Marlar RA; Maxwell NG; Aster RH
    Transfusion; 1983; 23(3):265-7. PubMed ID: 6407160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired cell-mediated immunity in patients with classic hemophilia.
    Lederman MM; Ratnoff OD; Scillian JJ; Jones PK; Schacter B
    N Engl J Med; 1983 Jan; 308(2):79-83. PubMed ID: 6216408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.